Loss or significant reduction of ARID1A protein expression is associated with heterozygous ARID1A mutations 1, 8, 9, suggesting a dominant‐negative tumour suppressor role (see 10 for a comprehensive review). The gene discussed is ARID1A; the disease is neoplasm.